PMC:7556165 / 70534-70942
Annnotations
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T393 | 174-184 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T394 | 174-178 | Species | denotes | SARS | NCBItxid:694009 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T419 | 0-408 | Sentence | denotes | The administration of a large amount of soluble form of ACE2 could represent an intriguing opportunity, since excessive ACE2 may exert dual functions: (a) competitively bind SARS-CoV-2 to neutralize the virus and/or slow viral entry in the host cell; (b) rescue cellular ACE2 activity, which negatively regulates RAAS and may theoretically exert a protective effect in lung injury (Verdecchia et al., 2020a). |
LitCovid-sample-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T150 | 369-373 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
1932 | 56-60 | Gene | denotes | ACE2 | Gene:59272 |
1933 | 120-124 | Gene | denotes | ACE2 | Gene:59272 |
1934 | 271-275 | Gene | denotes | ACE2 | Gene:59272 |
1936 | 174-184 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1940 | 369-380 | Disease | denotes | lung injury | MESH:D055370 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T6180 | 56-60 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
T6181 | 120-124 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
T6182 | 271-275 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T285 | 140-149 | http://purl.obolibrary.org/obo/BFO_0000034 | denotes | functions |
T286 | 203-208 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T287 | 227-244 | http://purl.obolibrary.org/obo/GO_0044409 | denotes | entry in the host |
T288 | 240-244 | http://purl.obolibrary.org/obo/IDO_0000531 | denotes | host |
T289 | 245-249 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T456 | 245-249 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T457 | 369-373 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T416 | 174-184 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T417 | 174-178 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T418 | 374-380 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
LitCovid-sample-PD-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T136 | 369-373 | http://purl.obolibrary.org/obo/MAT_0000135 | denotes | lung |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T151 | 221-249 | http://purl.obolibrary.org/obo/GO_0046718 | denotes | viral entry in the host cell |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T156 | 221-249 | http://purl.obolibrary.org/obo/GO_0046718 | denotes | viral entry in the host cell |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1932 | 56-60 | Gene | denotes | ACE2 | Gene:59272 |
1933 | 120-124 | Gene | denotes | ACE2 | Gene:59272 |
1934 | 271-275 | Gene | denotes | ACE2 | Gene:59272 |
1936 | 174-184 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1940 | 369-380 | Disease | denotes | lung injury | MESH:D055370 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T419 | 0-408 | Sentence | denotes | The administration of a large amount of soluble form of ACE2 could represent an intriguing opportunity, since excessive ACE2 may exert dual functions: (a) competitively bind SARS-CoV-2 to neutralize the virus and/or slow viral entry in the host cell; (b) rescue cellular ACE2 activity, which negatively regulates RAAS and may theoretically exert a protective effect in lung injury (Verdecchia et al., 2020a). |